Tag: Cancer: Skin
Life Expectancy Doesn’t Influence Care of Keratinocyte Carcinoma
No differences in rates of MMS, excision, ED&C for those with limited versus normal life expectancy
No Conclusive Link Between Melanoma Risk, PDE5 Inhibitors
Researchers say skin cancer in these patients is likely due to more sun exposure
Soles of the Feet Should Also Be Checked for Skin Cancer
Cutaneous melanoma is rare on feet, but often advanced when diagnosed
Melanoma Risk Up Slightly With PDE5 Inhibitors
Researchers say skin cancer in these patients is likely due to more sun exposure
Lip Cancer Risk Up for Some Solid Organ Transplant Recipients
Cancer risk up with high mean daily dose of azathioprine, longer duration of immunosupression
Some Sun Protection Behaviors Up With History of NMSC
Individuals with previous nonmelanoma skin cancer more often use shade, protective clothing
ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
ATS: Aggressive Melanoma Linked to Severe, Untreated Sleep Apnea
Study highlights the importance of diagnosing and treating obstructive sleep apnea
Rapid-Onset Diabetes Described With Anti-PD-1 Treatment
Case report of rapid-onset insulin-dependent diabetes with anti-programmed cell death 1 therapy
Pembrolizumab Active in Patients With Advanced Melanoma
Overall response rate of 33 percent for total population, 45 percent among treatment naive
